Vitenskapelig artikkel
-
Borda, Miguel Germán; Ramírez-Vélez, Robinson; Botero-Rodriguez, Felipe
et al. (2025). Anthocyanin supplementation in adults at risk for dementia: a randomized controlled trial on its cardiometabolic and anti-inflammatory biomarker effects. (ekstern lenke)
-
Borda, Miguel Germán; Barreto, George E.; Baldera, Jonathan Patricio
et al. (2024). A randomized, placebo-controlled trial of purified anthocyanins on cognitive function in individuals at elevated risk for dementia: Analysis of inflammatory biomarkers toward personalized interventions. (ekstern lenke)
-
Aarsland, Dag; Khalifa, Khadija; Bergland, Anne Katrine
et al. (2022). A Randomised Placebo-Controlled Study of Purified Anthocyanins on Cognition in Individuals at Increased Risk for Dementia. (ekstern lenke)
-
Oesterhus, Ragnhild; Dalen, Ingvild; Bergland, Anne Katrine
et al. (2020). Risk of Hospitalization in Patients with Alzheimer’s Disease and Lewy Body Dementia: Time to and Length of Stay. (ekstern lenke)
-
Bergland, Anne Katrine; Proitsi, Petroula; Kirsebom, Bjørn-Eivind
et al. (2020). Exploration of plasma lipids in mild cognitive impairment due to Alzheimer's disease. (ekstern lenke)
-
Khalifa, Khadija; Bergland, Anne Katrine; Sønnesyn, Hogne
et al. (2020). Effects of purified anthocyanins in people at risk for dementia: Study protocol for a phase II randomized controlled trial. (ekstern lenke)
-
Bergland, Anne Katrine; Sønnesyn, Hogne; Dalen, Ingvild
et al. (2019). Effects of anthocyanin supplementation on serum lipids, glucose, markers of inflammation and cognition in adults with increased risk of dementia - A pilot study. (ekstern lenke)
-
Bergland, Anne Katrine; Dalen, Ingvild; Larsen, Alf Inge
et al. (2016). Effect of Vascular Risk Factors on the Progression of Mild Alzheimer's Disease and Lewy Body Dementia. (ekstern lenke)
Vitenskapelig foredrag
Leserinnlegg
Leder
Errata
Se en full oversikt over publikasjoner i Cristin